Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 6Phase 1 5Phase 1/2 3Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 18INDUSTRY 11NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2CNS 2Dermatologic 1

Conditions

Untreated Childhood Anaplastic Astrocytoma 1Skin Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 44Biopsy 35Specimen Handling 34Magnetic Resonance Spectroscopy 30fludarabine 27aldesleukin 26Filgrastim 20Carboplatin 20Paclitaxel 19fludarabine phosphate 17Rituximab 17Sirolimus 16Cisplatin 16Temozolomide 15Radiotherapy 14Etoposide 14Bevacizumab 14Prednisone 13Gemcitabine 13Docetaxel 13Cytarabine 13Erlotinib Hydrochloride 12Fluorouracil 11Vorinostat 10Vincristine 10Sorafenib 10Electrocardiography 10Doxorubicin 10temsirolimus 9pembrolizumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × NIH × Gefitinib × Clear all
NCT00052208 2020-10-30

Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1/2 Completed
158 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00042991 2014-05-28

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

National Cancer Institute (NCI)

Phase 1/2 Completed
69 enrolled 27 charts
CNSSarcoma

Untreated Childhood Anaplastic Astrocytoma

NCT00423397 2013-12-19

Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
16 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡